The Novel Coronavirus 2019, was first reported on in Wuhan, China in late December 2019.  The outbreak was declared a public health emergency of international concern in January 2020 and on March 11th, 2020, the outbreak was declared a global pandemic.  The spread of this virus is now global with lots of media attention.  The virus has been named SARS-CoV-2 and the disease it causes has become known as coronavirus disease 2019 (COVID-19). This new outbreak has been producing lots of hysteria and false truths being spread, however the data surrounding the biology, epidemiology, and clinical characteristics are growing daily, making this a moving target.

REBEL COVID-19

will serve as a summary of what is currently known, how to screen, when to test, and how to prevent spread, and any new data/information on COVID-19.

  • All Categories
  • Cardiovascular
  • Endocrine, Metabolic, Fluid, and Electrolytes
  • Hematology and Oncology
  • Infectious Disease
  • Neurology
  • Pediatrics
  • Procedures and Skills
  • Resuscitation
  • Thoracic and Respiratory
All Categories
  • All Categories
  • Cardiovascular
  • Endocrine, Metabolic, Fluid, and Electrolytes
  • Hematology and Oncology
  • Infectious Disease
  • Neurology
  • Pediatrics
  • Procedures and Skills
  • Resuscitation
  • Thoracic and Respiratory

Be Heard In a Respirator Mask

Background: A major challenge during the COVID pandemic is balancing personal protection and communication. Being heard while wearing a surgical mask or N95 isn’t too much of a challenge, communication can be significantly impaired while wearing a respirator mask. There ...

Read More
Resuscitation

COVID-19 Update: Convalescent Plasma Therapy & Anticoagulation

Background: Medicine by press release has been an unfortunate reality of the COVID-19 pandemic.  This is not the standard many physicians would use for medical decision making, but one many of us have had to face; what do I do ...

Read More
Infectious Disease

COVID-19 Update: Time to Let Go of Convalescent Plasma Therapy

Background: Early observational studies led to the Emergency Use Authorization (EUA) for convalescent plasma therapy (CPT) in the US in August 2020 for the treatment of COVID-19. Data from the RECOVERY trial, the largest clinical trial on COVID-19 treatments was ...

Read More
Infectious Disease

Vitamin D Does Not Decrease Hospital Length of Stay in COVID-19

Background: As the COVID pandemic rages on, we continue to search for treatments to help combat the disease. Severely ill patients commonly have low levels of vitamin D and it has been suggested that optimal levels of Hydroxyvitamin D may ...

Read More
Infectious Disease

The STOIC Trial: Inhaled Budesonide in the Treatment of Early COVID-19

Background: COVID-19 typically starts as a mild illness that progresses over several days. Most treatment interventions for COVID-19 are focused on hospitalized patients who have progressed past this mild illness.  Monoclonal antibodies have been heavily touted in this role for ...

Read More

Does D Stand for Decrease Deterioration + Death? – The Jury is Out for Vitamin D in COVID

Update: This article was removed from the Lancet server on February 19th, 2021 (Link) Background: Vitamin D deficiency is common amongst critically ill patients and there has been ample speculation about a possible role for supplementation (with calcifediol) in the ...

Read More
Infectious Disease

REBEL Cast Ep95: Colchicine in COVID (COLCORONA)? Don’t Believe the Hype.

Background: Science by press release. Not the way any of us would choose to operate but, the COVID pandemic has made this a reality. It’s vital that we understand that while pharmaceutical companies have a responsibility to release this information, ...

Read More
Infectious Disease

The RECOVERY Trial: Tocilizumab

Background: Publication of the RECOVERY trial results on Dexamethasone were game changing – the drug had a clear reduction in mortality in patients requiring oxygen. Since then, we have had little to celebrate in terms of therapeutics in those with ...

Read More
Infectious Disease

BLAZE-1 Final Publication: Monoclonal Antibody Cocktail Part II

Background: One of the many massive challenges of the COVID19 pandemic has been the lack of targeted therapeutics. Extensive efforts have been invested into research with only glimmers of benefit for most drugs. The exception to this has been dexamethasone ...

Read More
Infectious Disease

COVID-19 Awake Proning – All Hype?

Background: Facilities around the world have seen surges of COVID-19 pneumonia  patients who have required protracted hospitalizations leading to overwhelmed hospital systems. Awake proning is a practice that was adopted early in the pandemic as a means to avoid, or ...

Read More
Infectious DiseaseThoracic and Respiratory

Sponsored